Moderna announces publication of preclinical data for chikungunya antibody program
Moderna announced publication of preclinical data in Science Immunology, showing that mRNA encoding a human monoclonal antibody against the chikungunya virus delivered in a proprietary lipid nanoparticle can protect from infection by the virus in vivo. May 17, 2019